PMVP

0.876033.13%
MC

Michael Carulli

CFO & Principal Financial & Accounting Officer

Mr. Michael Carulli serves as Chief Financial Officer at PMV Pharmaceuticals, Inc. since January 5, 2024 and serves as its Principal Financial Officer and Principal Accounting Officer since January 5, 2024 and had been its Senior Vice President of Finance from March 2023 and prior to that, as Vice President of Finance from May 2020 to March 2023. Prior to joining PMV Pharma, Mr. Carulli was an Executive Director of R&D Financial Planning and Analysis at Celgene (now Bristol Myers Squibb) where he oversaw the financial and operational plans for the entire Research and Development organization. Over years at Celgene he held multiple positions with increasing responsibility working closely on the R&D strategy, long range planning and financial Partnering to the Business Development and Alliance Management team. He was the Chief of Staff to the President of Research & Early Development for few years, as well as the R&D finance lead for the Bristol Myers Squibb integration and Otezla divestiture to Amgen. Combined, Mr. Carulli has financial management experience and has led many process improvement initiatives and implemented several business intelligence technology solutions. Mr. Carulli received a B.S. in Marketing and Management from Siena College and his MBA from Fordham Gabelli School of Business.

Positions